VSee Health Shares Surge 29.5% Amid Heavy Trading and SEC Filings
By ATTN Desk · Editorial oversight: Sean Han
Introduction
VSee Health Inc (ticker: VSEE) is a telemedicine technology provider headquartered in San Jose, California. Founded in 2008, the company offers a HIPAA-compliant platform that combines no-code and low-code building blocks, video conferencing, patient monitoring, and EHR integration. Its solutions support use cases ranging from urgent care and telepsychiatry to e-ICU and remote patient monitoring.
Corporate Structure
VSee Health employs between 51 and 200 individuals, according to LinkedIn data. The privately held company maintains its own video engine, enabling simultaneous streaming of clinical video and medical-device feeds (for example, digital otoscopes and EKGs) without additional integrations. Leadership and engineering teams focus on delivering configurable, white-label telehealth systems and on-demand remote physician services.
Telemedicine by Mary Eineman
Developments and News
- On October 21, 2025, VSee’s share price increased by 29.51% to $0.6324 on the NASDAQ, with trading volume totaling 17,310,131 shares.
- On October 20, 2025, the company filed an 8-K (SEC Acc-no: 0001185185-25-001496), reporting material events under Items 1.01, 2.03, and 9.01.
- On October 15, 2025, VSee submitted its Form 10-Q for the quarter ended June 30, 2025 (SEC Acc-no: 0001185185-25-001450), and a separate 10-Q for the quarter ended March 31, 2025 (SEC Acc-no: 0001185185-25-001448).
- VSee announced its AI & Digital Health User Conference, VSeeCON 2025: Profit and Impact, scheduled for November 12–13, 2025, in Silicon Valley, with a call for speakers and early-bird registration available via LinkedIn.
Financial and Strategic Analysis
| Metric | Value |
|---|---|
| Share Price (2025-10-21) | $0.6324 (+29.51%) |
| Volume | 17,310,131 |
| Market Cap | $10.724 million |
| Shares Outstanding | 17.02 million |
| 52-Week Range | $0.46 – $3.54 |
| Revenue (TTM) | $10.421 million |
| Gross Margin (TTM) | 68.87% |
| Net Margin (TTM) | -553.69% |
| EPS (TTM) | -3.94 |
| P/E (TTM) | -0.16 |
| Debt to Equity (MRQ) | 49,786.37% |
The year-to-date decline of 57.35% in the stock price, along with negative earnings and high leverage, reflects ongoing investment in product development and market expansion. VSee’s low-code, white-label telehealth stack and proprietary video engine support collaborations with organizations such as Health Tech Without Borders (2023 Clinton Global Initiative commitment) and partnerships with NASA’s International Space Station program.
Market Position and Industry Context
VSee operates in the telemedicine sector, competing with both specialty platforms and general collaboration tools (for example, Zoom). Its HIPAA-compliance, device-integration capabilities, and clinician services (branded iDoc) serve health systems, payers, and remote care providers. With increasing regulatory focus and patient demand driving digital health adoption, VSee aims to leverage its configurable architecture and partner ecosystem to address diverse workflows and enhance virtual-care delivery.
TL;DR
VSee’s shares rose 29.51% to $0.6324 on October 21, 2025, amid heavy trading. The company filed an 8-K on October 20 and two 10-Qs on October 15. It is preparing for VSeeCON 2025 on November 12–13, showcasing its low-code telehealth platform and remote physician services. Market pressures include high leverage and negative margins, while industry trends favor increased virtual-care adoption.